retatrutide for type 2 diabetes 💉 A triple-action once-weekly injection can significantly lower blood sugar and body weight in people with diabetes, a new phase 3 trial shows. is part of an emerging generation Retatrutide Phase 2: Type 2

Effect of weekly subcutaneous semaglutide vs daily liraglutide on body weight in adults with overweight or obesity without diabetes : the STEP 8 randomized clinical trial // Jama

The prior authorization process requires health care providers to certify that a member is enrolled in an approved weight loss program and meets the necessary medical criteria for GLP-1 therapy

Not everyone, however, was convinced that glucagon needed to be blocked to encourage weight loss

Doctors can usually prescribe different medications within the same class, like GLP-1 receptor agonists, based on clinical judgment, although [this] varies due to factors like insurance requirements, formulary restrictions, medical history, and treatment goals, said Yoshua Quinones, MD, an internist with Medical Offices of Manhattan and contributor to LabFinder

Anyone enrolled in a retatrutide clinical trial who experiences concerning symptoms should contact their trial team promptly

Glucagon receptor activation drives energy expenditure through thermogenesis, promotes hepatic fat oxidation, and enhances lipolysis in ways that GLP-1 activation alone simply cannot achieve